NHS to offer 'life-changing' gene therapy for blood disorder thalassaemia

A new gene therapy treatment called Casgevy has been approved for patients with severe thalassaemia in England. This therapy offers hope for a cure and a better quality of life for hundreds with this debilitating blood disorder, predominantly affecting those of Mediterranean, Asian, or Middle Eastern heritage.